These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6141730)

  • 1. Effects of topical betaxolol, timolol, and placebo on pulmonary function in asthmatic bronchitis.
    Schoene RB; Abuan T; Ward RL; Beasley CH
    Am J Ophthalmol; 1984 Jan; 97(1):86-92. PubMed ID: 6141730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of topical ophthalmic instillation of timolol and betaxolol on lung function in asthmatic subjects.
    Dunn TL; Gerber MJ; Shen AS; Fernandez E; Iseman MD; Cherniack RM
    Am Rev Respir Dis; 1986 Feb; 133(2):264-8. PubMed ID: 3946922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Corneal sensitivity after single doses of timolol, betaxolol or placebo in persons with healthy eyes--a randomized, prospective double-blind study].
    Höh H
    Fortschr Ophthalmol; 1988; 85(2):132-8. PubMed ID: 2899042
    [No Abstract]   [Full Text] [Related]  

  • 4. Topical beta-blockade with intrinsic sympathomimetic activity offers no advantage for the respiratory and cardiovascular function of elderly people.
    Diggory P; Cassels-Brown A; Fernandez C
    Age Ageing; 1996 Nov; 25(6):424-8. PubMed ID: 9003876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular effects of befunolol, betaxolol and timolol eye drops.
    Dorigo MT; Cerin O; Fracasso G; Altafini R
    Int J Clin Pharmacol Res; 1990; 10(3):163-6. PubMed ID: 1977708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment with betaxolol and placebo eyedrops in patients with glaucoma and reactive airway diseases].
    Bleckmann H; Dorow P
    Klin Monbl Augenheilkd; 1987 Sep; 191(3):199-202. PubMed ID: 2890791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the efficacy of betaxolol and timolol in ocular hypertension with or without adrenaline.
    Clark JB; Brooks AM; Harper CA; Mantzioros N; Gillies WE
    Aust N Z J Ophthalmol; 1989 May; 17(2):173-7. PubMed ID: 2569321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of topical timolol vs betaxolol on cardiopulmonary exercise performance in healthy volunteers.
    Dickstein K; Hapnes R; Aarsland T; Kristianson K; Viksmoen L
    Acta Ophthalmol (Copenh); 1988 Aug; 66(4):463-6. PubMed ID: 2904203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of topical betaxolol, timolol, and placebo on pulmonary function in asthmatic bronchitis.
    Spiritus EM; Casciari R
    Am J Ophthalmol; 1985 Sep; 100(3):492-4. PubMed ID: 4037047
    [No Abstract]   [Full Text] [Related]  

  • 10. Betaxolol in patients with glaucoma and asthma.
    Van Buskirk EM; Weinreb RN; Berry DP; Lustgarten JS; Podos SM; Drake MM
    Am J Ophthalmol; 1986 May; 101(5):531-4. PubMed ID: 3706457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of beta-adrenoceptors blocking eye drops in patients with chronic bronchitis.
    Hugues FC; Matte JC; Le Jeunne C; Salem A
    Therapie; 1992; 47(3):211-5. PubMed ID: 1363497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The lack of efficacy of topical beta-blockers, timolol and betaxolol on intraocular pressure in Nigerian healthy volunteers.
    Olateju SO; Ajayi AA
    Eye (Lond); 1999 Dec; 13 ( Pt 6)():758-63. PubMed ID: 10707140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular effects of topical beta-blockers during exercise.
    Atkins JM; Pugh BR; Timewell RM
    Am J Ophthalmol; 1985 Feb; 99(2):173-5. PubMed ID: 3970121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison in healthy volunteers of the systemic beta adrenergic receptor blockade by beta blockader eye drops].
    de Dieuleveult C; Queinnec MC; Pinaud M; Souron R
    Ann Fr Anesth Reanim; 1989; 8(1):46-50. PubMed ID: 2565697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta 1- and beta 2-antagonist activity of topically applied betaxolol and timolol in the systemic circulation.
    Vuori ML; Ali-Melkkilä T; Kaila T; Iisalo E; Saari KM
    Acta Ophthalmol (Copenh); 1993 Oct; 71(5):682-5. PubMed ID: 7906474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of short- and long-term effects of betaxolol and timolol on human retinal circulation.
    Yoshida A; Ogasawara H; Fujio N; Konno S; Ishiko S; Kitaya N; Kagokawa H; Nagaoka T; Hirokawa H
    Eye (Lond); 1998; 12 ( Pt 5)():848-53. PubMed ID: 10070522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of bronchial effects following topical administration of butylamino-phenoxy-propanol-acetate, an oculoselective beta-adrenoceptor blocker in asthmatic subjects.
    Bauer KG; Brunner-Ferber F; Distlerath LM; Lippa EA; Binkowitz B; Till P; Kaik GA
    Br J Clin Pharmacol; 1992 Aug; 34(2):122-9. PubMed ID: 1358158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical beta-blocker therapy and central nervous system side effects. A preliminary study comparing betaxolol and timolol.
    Lynch MG; Whitson JT; Brown RH; Nguyen H; Drake MM
    Arch Ophthalmol; 1988 Jul; 106(7):908-11. PubMed ID: 2898932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of systemic adverse reactions induced by ophthalmic beta-adrenergic receptor antagonists.
    Yamada Y; Takayanagi R; Tsuchiya K; Ito K; Ohtani H; Sawada Y; Iga T
    J Ocul Pharmacol Ther; 2001 Jun; 17(3):235-48. PubMed ID: 11436944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of timolol, betaxolol, and placebo on corneal sensitivity in healthy volunteers.
    Vogel R; Clineschmidt CM; Hoeh H; Kulaga SF; Tipping RW
    J Ocul Pharmacol; 1990; 6(2):85-90. PubMed ID: 2394934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.